Resource Needs for the Trivalent Oral Polio to Bivalent Oral Polio Vaccine Switch in Indonesia

Journal of Infectious Diseases

Volumn 216, Issue , 2017, Pages S209-S216

  Holmes, Marionette ^a,b   Abimbola, Taiwo ^a   Lusiana, Merry ^c   Pallas, Sarah ^a   Hampton, Lee M ^a   Widyastuti, Retno ^c   Muas, Idawati ^c   Karlina, Karlina ^c   Kosen, Soewarta ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b SPELMAN COLLEGE   (United States)

^c MINISTRY OF HEALTH   (Indonesia)

Author keywords

cost analysis; Indonesia.; resource utilization; vaccine switch

Indexed keywords

BIVALENT ORAL POLIO VACCINE; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG SUBSTITUTION; EMPIRICAL RESEARCH; GEOGRAPHY; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; INDONESIA; POLIOMYELITIS; PRIORITY JOURNAL; PROGRAM EVALUATION; PUBLIC HEALTH SERVICE; RESOURCE ALLOCATION; COST; ECONOMICS; EPIDEMIOLOGY; PREVENTIVE HEALTH SERVICE; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION;

COSTS AND COST ANALYSIS; DRUG SUBSTITUTION; HUMANS; IMMUNIZATION PROGRAMS; INDONESIA; POLIOMYELITIS; POLIOVIRUS VACCINE, ORAL;

EID: 85023184218     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jix073     Document Type: Article

References (18)

1. Hampton LM, Farrell M, Ramirez-Gonzalez A, et al.; Immunization Systems Management Group of the Global Polio Eradication Initiative. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine worldwide, 2016. MMWR Morb Mortal Wkly Rep 2016; 65:934-8
2. Kew OM, Sutter RW, Gourville EM, Dowdle WR, Pallansch MA. Vaccinederived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 2005; 59:587-635
3. Morales M, Tangermann RH, Wassilak SG. Progress toward polio eradication worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep 2016; 65:470-3
4. World Health Organization. Meeting of the strategic advisory group of experts on immunization, October 2015-conclusions and recommendations. Wkly Epidemiol Rec 2015; 50:681-700
5. World Health Organization. The Switch from tOPV to bOPV implementation guidelines: a handbook for national decision makers, programme managers, logisticians, and consultants. http://www.who.int/immunization/diseases/poliomyelitis/ endgame-objective2/oral-polio-vaccine/implementation/en/. Accessed 9 September 2016
6. Shendale S, Farrell M, Hampton LM, et al. Financial support to eligible countries for the switch from trivalent to bivalent oral polio vaccine-lessons learned. J Infect Dis 2017; 216 (suppl 1):52-6
7. World Health Organization. Global Polio Eradication Iniative. The switch from tOPV to bOPV: implementation guidelines. Geneva, Switzerland: World Health Organization, 2016
8. World Bank. Indonesia GDP per capita 1967-2015. http://data.worldbank.org/ indicator/NY.GDP.PCAP.CD?locations=ID. Accessed 19 September 2016
9. Bahl S, Kumar R, Menabde N, et al. Polio-free certification and lessons learned-South-East Asia region, March 2014. MMWR Morb Mortal Wkly Rep 2014; 63:941-6
10. Burns CC, Diop OM, Sutter RW, Kew OM. Vaccine-derived polioviruses. J Infect Dis 2014; 210(suppl 1):283-93
11. Centers for Disease Control and Prevention. Resurgence of wild poliovirus type 1 transmission and consequences of importation-21 countries, 2002-2005. MMWR Morb Mortal Wkly Rep 2006;55:145-50
12. Ministry of Health, Republic of Indonesia. Road map: eradicating polio in Indonesia. Jakarta, Indonesia: Directorate General Disease Control &Prevention, Indonesian Ministry of Health, 2015
13. Ministry of Health, Republic of Indonesia, Directorate General of Disease Control and Environmental Health. National polio vaccine switch plan. Jakarta, Indonesia: Directorate General Disease Control &Prevention, Indonesian Ministry of Health, 2015
14. Brenzel L, et al. Costs and financing of routine immunization: approach and selected findings of a multi-country study (EPIC). Vaccine 2015; 33(suppl 1): 13-20
15. Griffiths UK, et al. Incremental system costs of introducing combined DTwPhepatitis B-Hib vaccine into national immunization services in Ethiopia. Vaccine 2009; 27:1426-32
16. Cohen MD, Hawes DR, Hutchins GD, McPhee WD, LaMasters MB, Fallon RP. Activity-based cost analysis: a method of analyzing the financial and operating performance of academic radiology departments. Radiology 2000; 215:708-16
17. Kaplan RS, Anderson RS. Time-driven activity-based costing: a simpler and more powerful path to higher profits. Boston: Harvard Business School Press; 2007
18. International Monetary Fund. Representative exchange rates for selected currencies. https://www.imf.org/external/np/fin/data/rms-rep.aspx. Accessed 19 September 2016